TRxADE HEALTH, Inc. (MEDS) Research

TRxADE HEALTH, Inc. operates as a healthcare technology firm within the United States. Its central aim is to modernize the retail pharmacy landscape by digitally enhancing drug acquisition, the prescription journey, and patient interactions. The company manages the TRxADE marketplace, a platform that promotes pricing clarity for pharmaceutical products and serves approximately 11,800 members. Additionally, it provides patient-centric telehealth services under its Bonum Health brand. Based in Land O' Lakes, Florida, the organization was rebranded as TRxADE HEALTH, Inc. in June 2021, having formerly operated as Trxade Group, Inc.

Market snapshot

Symbol
MEDS
Price
$7.59
Day change
+4.55%
Market cap
$13.3M
P/E ratio
-0.07x
52-week range
3.69-44.56
Sector
Healthcare
Industry
Medical - Pharmaceuticals

Peer companies

  • Axcella Health Inc. (AXLA)
  • Babylon Holdings Limited (BBLNF)
  • Cano Health, Inc. (CANO)
  • China Jo-Jo Drugstores, Inc. (CJJD)
  • Celyad Oncology S.A. (CYAD)
  • Dole plc (DOLE)
  • 23andMe Holding Co. (ME)
  • Reunion Neuroscience Inc. (REUN)

Recent insider activity

  • Shankar Hariharan — trade (0 shares) on 2024-07-25
  • Shankar Hariharan — trade (0 shares) on 2024-07-25
  • Shankar Hariharan — trade (1916816 shares) on 2024-07-25
  • Shankar Hariharan — trade (356480 shares) on 2024-07-25
  • Narasimhan Mani — trade (0 shares) on 2024-07-25

Open TRxADE HEALTH, Inc. (MEDS) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.